Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
Cibus, Inc. Q1 2026 Earnings Call Summary
Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Cibus Q1 Earnings Call Highlights
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Cibus (NASDAQ:CBUS) Edges Past Q1 Estimates as Cost Cutting Narrows Loss, Stock Jumps After-Hours
Cibus Reports First Quarter Financial Results and Provides Business Update
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus Q1 2026 Earnings Call: Complete Transcript
Cibus Q1 EPS $(0.33), Inline, Sales $1.681M Beat $1.616M Estimate
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
Cibus Announces the Election of Thomas Urban to Board of Directors
Cibus shares are trading lower after the company announced a public offering of 6.98 million shares at $2.15 each.
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock
Cibus Prices Public Offering Of 6.98M Shares At $2.15 Each
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants
Cibus shares are trading lower after the company announced a proposed public offering.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.